Real-time enrollment status for this brain metastases clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT05438212 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Brain Metastases |
| Phase | Clinical Trial |
| Target Enrollment | 236 participants |
| Active Locations | 207 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | January 14, 2026 (Jan 14, 2026) |
As of March 2, 2026: Clinical trial NCT05438212 is currently active_not_recruiting participants. This clinical trial study for brain metastases is not currently accepting new participants at 207 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05438212 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 207 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05438212 was last updated Jan 14, 2026 (January 14, 2026). HelloStudys verifies this status automatically.